Astrana Health (NASDAQ:ASTH) Earns Buy Rating from Analysts at Needham & Company LLC
Equities researchers at Needham & Company LLC initiated coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a research note issued to investors on Friday, Marketbeat.com reports. The firm set a “buy” rating and a $28.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside […]
13 Dec 13:02 · The Markets Daily